Eczema is a group of inflammatory and chronic skin conditions, and it is the most common skin disease among older people. As many as one in two people aged over 60 suffer from some form of eczema. A ...

Amgen (NasdaqGS:AMGN) ended its eczema drug partnership with Kyowa Kirin involving the experimental therapy rocatinlimab. The ...

Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a ...

CI Labs, a Singapore-based wellness brand focused on gentle and effective skincare, announced the launch of its CI Labs Eczema Relief Cream, a non-steroidal formulation developed to support ...

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

“Whilst most cases of impetigo are not serious and can heal on their own, leaving impetigo untreated can lead to more serious ...

The doctor has said that "it often comes in intervals about every three to four weeks" ...

Kyowa Kirin will file for rocatinlimab’s US approval, which was once Amgen’s most late-stage pipeline candidate.

A Geelong mum-of-three has searched far and wide for a uniform her eczema-suffering son can wear without triggering painful ...

Researchers are using toy-inspired technology to help relieve eczema, a painful, itchy condition affecting tens of millions in the U.S.